\
&
Contact us
\
&
Contact us
Published on | 6 months ago
Programmes MissionsAt the Cities Mission Conference in Vilnius, 39 cities participating in the EU Mission for climate neutral and smart cities have received the EU Mission label. This recognition highlights their ambitious plans to reach climate neutrality by 2030 and is designed to help them unlock public and private funding to support this goal. Antwerp is one of those 39 cities and is the second city from Flanders after Leuven in 2024 to receive this title. You can find more information on this webpage.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
